North Berkeley Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
4,572
+720
+19% +$168K 0.47% 33
2026
Q1
$942K Buy
3,852
+200
+5% +$46.6K 0.5% 33
2025
Q4
$756K Buy
3,652
+793
+28% +$157K 0.45% 35
2025
Q3
$530K Sell
2,859
-78
-3% -$13.4K 0.42% 35
2025
Q2
$449K Buy
2,937
+867
+42% +$133K 0.41% 38
2025
Q1
$343K Sell
2,070
-76
-4% -$11.9K 0.36% 44
2024
Q4
$310K Buy
+2,146
New +$333K 0.32% 48

Other funds holding JNJ

North Berkeley Wealth Management's JNJ Position: Q2 2026 in Review

North Berkeley Wealth Management increased its Johnson & Johnson (JNJ) stake by 19% in Q2 2026, buying an estimated $168K and bringing the position to 4,572 shares worth $1.16M. The position accounts for 0.47% of the portfolio, ranked #33.

North Berkeley Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • North Berkeley Wealth Management held 4,572 shares of Johnson & Johnson worth $1.16M as of Q2 2026.
  • North Berkeley Wealth Management bought 720 Johnson & Johnson shares in Q2 2026, an estimated $168K.
  • Johnson & Johnson made up 0.47% of North Berkeley Wealth Management's portfolio in Q2 2026, its #33 holding.
  • North Berkeley Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on North Berkeley Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.